Delivery of KN-93 targeted to CD4 T cells to lupus-prone MRL/lpr mice increased IL-2 levels in the serum, reduced IL-17 producing infiltrating cells in the kidneys and improved kidney function as measured by proteinuria. The gene discussed is IL17A; the disease is systemic lupus erythematosus.